JAGXJaguar Health, Inc.
3.220USD-2.13%Mkt Cap: 2.10M USDP/E: Last update: 2026-06-01

Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal He…

Indicators:|

Key Statistics

Company
Market Cap2.10M USD
Enterprise Value37.07M USD
Revenue (TTM)29.57M USD
Gross Profit7.74M USD
Net Income (TTM)-53.43M USD
Revenue/Share154.72 USD
Last Price3.220 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees47
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-0.63
PEG
EV/EBITDA-1.57
EV/Revenue1.25
P/S0.08
P/B-0.09
EPS (TTM)-695.50
EPS (Forward)-5.68
52W Range
2.5300% of range161.70
52W High161.70 USD
52W Low2.530 USD
Profitability
Gross Margin67.21%
Oper. Margin50.23%
EBITDA Margin-79.81%
Profit Margin-464.20%
ROE309.06%
ROA-139.43%
Growth
Revenue Growth815.60%
Earnings Growth
Cash Flow & Leverage
Operating CF-23.69M USD
CapEx (TTM)41.00K USD
FCF Margin-7.05%
FCF Yield-99.14%
Net Debt27.03M USD
Net Debt/EBITDA-1.15
Balance Sheet
Debt/Equity-2.52
Current Ratio0.65
Quick Ratio0.24
Book Value/Sh-38.1150 USD
Cash/Share12.07 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateJun 7, 2019
Splits
Last Split1:35
Split DateApr 30, 2026
Analyst Consensus
Rating
Target (Mean)262.50 USD
Target Range262.50 USD262.50 USD
# Analysts1
Ownership
Shares Out.657.36K
Float576.58K
Insiders6.38%
Institutions1.22%
Short Interest
Short Ratio0.8d
Short % Float13.13%
Short % Out.13.13%
Shares Short67.48K
Short (prev mo.)17.14K
Technical
SMA 509.509 (-66.1%)
SMA 20038.93 (-91.7%)
Beta0.03
S&P 52W Chg27.94%
Avg Vol (30d)114.80K
Avg Vol (10d)154.69K
Technical Indicators
RSI (14)28.7
MACD-1.8890
MACD Signal-2.2886
MACD Hist.+0.3996
BB Upper5.108 USD
BB Middle3.466 USD
BB Lower1.823 USD
BB Width94.80%
ATR (14)0.8290 USD
Vol Ratio (20d)0.33x